CRISPR・CRISPR関連遺伝子群 (Cas遺伝子群) の世界市場：成長、動向、予測（2020年～2025年）
CRISPR and CRISPR-associated (Cas) Genes Market - Growth, Trends, and Forecast (2020 - 2025)
|CRISPR・CRISPR関連遺伝子群 (Cas遺伝子群) の世界市場：成長、動向、予測（2020年～2025年）|
発行: Mordor Intelligence LLP
ページ情報: 英文 120 Pages
世界のCRISPRおよびCRISPR関連 (cas) 遺伝子市場は、2020年から2025年の調査期間において26.8%のCAGRで推移することが予測されています。CRISPR-Cas9システムは、他の既存のゲノム編集方法よりも高速、安価、正確、効率的であるため、科学界に多大な意気込みをもたらしています。さらに、バイオテクノロジー企業による研究開発プログラムへの投資の増加と植物ゲノム編集プログラムの研究の増加が、当市場の成長加速を牽引しています。
当レポートでは、世界のCRISPR・CRISPR関連遺伝子群 (Cas遺伝子群) 市場を調査し、市場の概要、製品・用途・地域別の市場動向、市場規模の推移と予測、市場成長・阻害要因および市場機会の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。
The CRISPR and CRISPR-Associated (Cas) genes market studied was projected to grow with a CAGR of nearly 26.8% over the forecast period. The major factor attributing to the growth of the market increasing the adoption of the CRISPR-Cas9 system in genome editing and other biotechnological areas. The CRISPR-Cas9 system has created a lot of enthusiasm in the scientific community because it is faster, cheaper, more accurate, and more efficient than other existing genome editing methods. Furthermore, the growing investments in research and development programs by the biotechnology companies and increasing research in plant genome editing programs are boosting the market growth. However, the off-target effects associated with the implementation of CRISPR is a major drawback for market growth.
Genome engineering Segment Holds the Largest Share in the Market
The largest share of the segment in the market growth is accredited to the increasing adoption of genome editing techniques for germline alterations and therapeutic development. CRISPR holds the ability to become an alternative biotechnology treatment for supplementing or substitute for the existing single-antibody drugs. Genome editing that is meant to switch on the immune response for targeting cancer is expected to drive industrial growth significantly. The variety of available Cas proteins and flexibility of guide RNA production makes this technique a powerful system for all applications of genome editing. Furthermore, the increasing fundings allocated for the biotechnology and genomics research and development programs are driving the growth of the market.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall CRISPR and CRISPR-Associated (Cas) genes market, throughout the forecast period. The market growth is due to the factors such as the presence of key players, increasing funding in biotechnology and genomics programs, established healthcare infrastructure, are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region the United States has the maximum share due to supportive healthcare policies, the high incidence of chronic diseases, and a developed healthcare market.
The CRISPR and CRISPR-associated (Cas) genes market is moderately competitive and consists of several major players. Some of the market players are OriGene Technologies, Inc., Thermo Fisher Scientific, Takara Bio Inc, Horizon Discovery Ltd., Addgene, Merck KGaA, Caribou Biosciences, Inc., CRISPR THERAPEUTICS, Editas Medicine, Mirus Bio LLC.